Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

Angiographic completeness of PCI not tied to outcomes after FFR-guided stenting

Visual estimations of the completeness of revascularization failed to predict subsequent cardiovascular events for patients with acute coronary syndromes (ACS) who underwent stenting guided by fractional flow reserve (FFR), researchers reported in the Journal of the American College of Cardiology.

Thumbnail

COAPT, SOLVE-TAVI among major trials at TCT.18

Gregg W. Stone, MD, had the unenviable task of condensing the 255-page agenda for next weekend’s Transcatheter Cardiovascular Therapeutics (TCT) meeting into a handful of highlights during a 12-minute media briefing on Thursday, Sept. 13.

Thumbnail

TCT.18 Preview: Celebrating 30 Years & Unveiling a New Training Center

Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.

Thumbnail

Angiography, PCI improve outcomes in non-STEMI patients with kidney disease

Chronic kidney disease is a marker of adverse outcomes in patients with non-ST-elevation myocardial infarction (non-STEMI), according to a study published this month in the American Journal of Cardiology. And even though percutaneous coronary intervention (PCI) and coronary angiography (CAG) are linked to improved outcomes in those patients, they’re also drastically underutilized in clinical practice.

Thumbnail

Accomplished interventional cardiologist, advocate Joseph Babb dies

Joseph D. Babb, MD—who performed the first coronary angioplasty in the state of Connecticut and was a past president of the Society for Cardiovascular Angiography and Interventions (SCAI)—has died, SCAI announced Sept. 6. He was 79.

Thumbnail

Lawsuit: Surgeon left needle inside patient during open-heart surgery

The family of a Tennessee man who died in 2017, one month after open-heart surgery, is suing TriStar Centennial hospital, alleging the surgeon left a needle inside his body.

VISION: 75% of deaths after noncardiac surgery due to cardiovascular complications

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

1-year outcomes still support culprit-only PCI for cardiogenic shock

For patients with acute myocardial infarction (MI) complicated by cardiogenic shock, stenting only the culprit lesion showed a trend toward improved one-year survival when compared to multivessel PCI, according to the latest results of the CULPRIT-SHOCK trial presented at the European Society of Cardiology Congress in Munich.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.